Sterling Financial Planning, Inc. Bristol Myers Squibb CO Transaction History

Sterling Financial Planning, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $36,414 - $42,451	-679 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $59 - $69	1 Added 0.15%	679 $40,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $123 - $134	2 Added 0.3%	678 $45,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $2,551 - $2,869	-43 Reduced 5.98%	676 $43,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $41,515 - $47,044	719 New	719 $45,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sterling Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Sterling Financial Planning, Inc. with notifications on news.